Pharma & Healthcare
Global Atovaquone and Proguanil Market Research Report 2024
- Jan 18, 24
- ID: 3162
- Pages: 76
- Figures: 164
- Views: 23
Atovaquone/Proguanil Hydrochloride is a dose combination of atovaquone and proguanil hydrochloride which acts as a blood schizonticide and also has activity against hepatic schizonts of Plasmodium falciparum.
The global Atovaquone and Proguanil market was valued at US$ 129 million in 2023 and is anticipated to reach US$ 191.2 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
North American market for Atovaquone and Proguanil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Atovaquone and Proguanil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Atovaquone and Proguanil include GSK, Glenmark, Mylan Pharmaceuticals and Hetero, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Atovaquone and Proguanil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atovaquone and Proguanil.
Report Scope
The Atovaquone and Proguanil market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Atovaquone and Proguanil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atovaquone and Proguanil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Glenmark
Mylan Pharmaceuticals
Hetero
Segment by Type
250 mg/100 mg
62.5mg/25mg
Segment by Application
Adult
Paediatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Atovaquone and Proguanil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Atovaquone and Proguanil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Atovaquone and Proguanil market was valued at US$ 129 million in 2023 and is anticipated to reach US$ 191.2 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
North American market for Atovaquone and Proguanil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Atovaquone and Proguanil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Atovaquone and Proguanil include GSK, Glenmark, Mylan Pharmaceuticals and Hetero, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Atovaquone and Proguanil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atovaquone and Proguanil.
Report Scope
The Atovaquone and Proguanil market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Atovaquone and Proguanil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atovaquone and Proguanil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Glenmark
Mylan Pharmaceuticals
Hetero
Segment by Type
250 mg/100 mg
62.5mg/25mg
Segment by Application
Adult
Paediatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Atovaquone and Proguanil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Atovaquone and Proguanil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Atovaquone and Proguanil Market Overview
1.1 Product Overview and Scope of Atovaquone and Proguanil
1.2 Atovaquone and Proguanil Segment by Type
1.2.1 Global Atovaquone and Proguanil Market Value Comparison by Type (2024-2030)
1.2.2 250 mg/100 mg
1.2.3 62.5mg/25mg
1.3 Atovaquone and Proguanil Segment by Application
1.3.1 Global Atovaquone and Proguanil Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Paediatric
1.4 Global Atovaquone and Proguanil Market Size Estimates and Forecasts
1.4.1 Global Atovaquone and Proguanil Revenue 2019-2030
1.4.2 Global Atovaquone and Proguanil Sales 2019-2030
1.4.3 Global Atovaquone and Proguanil Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Atovaquone and Proguanil Market Competition by Manufacturers
2.1 Global Atovaquone and Proguanil Sales Market Share by Manufacturers (2019-2024)
2.2 Global Atovaquone and Proguanil Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Atovaquone and Proguanil Average Price by Manufacturers (2019-2024)
2.4 Global Atovaquone and Proguanil Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Atovaquone and Proguanil, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atovaquone and Proguanil, Product Type & Application
2.7 Atovaquone and Proguanil Market Competitive Situation and Trends
2.7.1 Atovaquone and Proguanil Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Atovaquone and Proguanil Players Market Share by Revenue
2.7.3 Global Atovaquone and Proguanil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Atovaquone and Proguanil Retrospective Market Scenario by Region
3.1 Global Atovaquone and Proguanil Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Atovaquone and Proguanil Global Atovaquone and Proguanil Sales by Region: 2019-2030
3.2.1 Global Atovaquone and Proguanil Sales by Region: 2019-2024
3.2.2 Global Atovaquone and Proguanil Sales by Region: 2025-2030
3.3 Global Atovaquone and Proguanil Global Atovaquone and Proguanil Revenue by Region: 2019-2030
3.3.1 Global Atovaquone and Proguanil Revenue by Region: 2019-2024
3.3.2 Global Atovaquone and Proguanil Revenue by Region: 2025-2030
3.4 North America Atovaquone and Proguanil Market Facts & Figures by Country
3.4.1 North America Atovaquone and Proguanil Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Atovaquone and Proguanil Sales by Country (2019-2030)
3.4.3 North America Atovaquone and Proguanil Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Atovaquone and Proguanil Market Facts & Figures by Country
3.5.1 Europe Atovaquone and Proguanil Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Atovaquone and Proguanil Sales by Country (2019-2030)
3.5.3 Europe Atovaquone and Proguanil Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atovaquone and Proguanil Market Facts & Figures by Country
3.6.1 Asia Pacific Atovaquone and Proguanil Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Atovaquone and Proguanil Sales by Country (2019-2030)
3.6.3 Asia Pacific Atovaquone and Proguanil Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Atovaquone and Proguanil Market Facts & Figures by Country
3.7.1 Latin America Atovaquone and Proguanil Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Atovaquone and Proguanil Sales by Country (2019-2030)
3.7.3 Latin America Atovaquone and Proguanil Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Atovaquone and Proguanil Market Facts & Figures by Country
3.8.1 Middle East and Africa Atovaquone and Proguanil Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Atovaquone and Proguanil Sales by Country (2019-2030)
3.8.3 Middle East and Africa Atovaquone and Proguanil Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Atovaquone and Proguanil Sales by Type (2019-2030)
4.1.1 Global Atovaquone and Proguanil Sales by Type (2019-2024)
4.1.2 Global Atovaquone and Proguanil Sales by Type (2025-2030)
4.1.3 Global Atovaquone and Proguanil Sales Market Share by Type (2019-2030)
4.2 Global Atovaquone and Proguanil Revenue by Type (2019-2030)
4.2.1 Global Atovaquone and Proguanil Revenue by Type (2019-2024)
4.2.2 Global Atovaquone and Proguanil Revenue by Type (2025-2030)
4.2.3 Global Atovaquone and Proguanil Revenue Market Share by Type (2019-2030)
4.3 Global Atovaquone and Proguanil Price by Type (2019-2030)
5 Segment by Application
5.1 Global Atovaquone and Proguanil Sales by Application (2019-2030)
5.1.1 Global Atovaquone and Proguanil Sales by Application (2019-2024)
5.1.2 Global Atovaquone and Proguanil Sales by Application (2025-2030)
5.1.3 Global Atovaquone and Proguanil Sales Market Share by Application (2019-2030)
5.2 Global Atovaquone and Proguanil Revenue by Application (2019-2030)
5.2.1 Global Atovaquone and Proguanil Revenue by Application (2019-2024)
5.2.2 Global Atovaquone and Proguanil Revenue by Application (2025-2030)
5.2.3 Global Atovaquone and Proguanil Revenue Market Share by Application (2019-2030)
5.3 Global Atovaquone and Proguanil Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Atovaquone and Proguanil Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Atovaquone and Proguanil Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Glenmark
6.2.1 Glenmark Corporation Information
6.2.2 Glenmark Description and Business Overview
6.2.3 Glenmark Atovaquone and Proguanil Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Glenmark Atovaquone and Proguanil Product Portfolio
6.2.5 Glenmark Recent Developments/Updates
6.3 Mylan Pharmaceuticals
6.3.1 Mylan Pharmaceuticals Corporation Information
6.3.2 Mylan Pharmaceuticals Description and Business Overview
6.3.3 Mylan Pharmaceuticals Atovaquone and Proguanil Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Pharmaceuticals Atovaquone and Proguanil Product Portfolio
6.3.5 Mylan Pharmaceuticals Recent Developments/Updates
6.4 Hetero
6.4.1 Hetero Corporation Information
6.4.2 Hetero Description and Business Overview
6.4.3 Hetero Atovaquone and Proguanil Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hetero Atovaquone and Proguanil Product Portfolio
6.4.5 Hetero Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atovaquone and Proguanil Industry Chain Analysis
7.2 Atovaquone and Proguanil Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atovaquone and Proguanil Production Mode & Process
7.4 Atovaquone and Proguanil Sales and Marketing
7.4.1 Atovaquone and Proguanil Sales Channels
7.4.2 Atovaquone and Proguanil Distributors
7.5 Atovaquone and Proguanil Customers
8 Atovaquone and Proguanil Market Dynamics
8.1 Atovaquone and Proguanil Industry Trends
8.2 Atovaquone and Proguanil Market Drivers
8.3 Atovaquone and Proguanil Market Challenges
8.4 Atovaquone and Proguanil Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Atovaquone and Proguanil
1.2 Atovaquone and Proguanil Segment by Type
1.2.1 Global Atovaquone and Proguanil Market Value Comparison by Type (2024-2030)
1.2.2 250 mg/100 mg
1.2.3 62.5mg/25mg
1.3 Atovaquone and Proguanil Segment by Application
1.3.1 Global Atovaquone and Proguanil Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Paediatric
1.4 Global Atovaquone and Proguanil Market Size Estimates and Forecasts
1.4.1 Global Atovaquone and Proguanil Revenue 2019-2030
1.4.2 Global Atovaquone and Proguanil Sales 2019-2030
1.4.3 Global Atovaquone and Proguanil Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Atovaquone and Proguanil Market Competition by Manufacturers
2.1 Global Atovaquone and Proguanil Sales Market Share by Manufacturers (2019-2024)
2.2 Global Atovaquone and Proguanil Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Atovaquone and Proguanil Average Price by Manufacturers (2019-2024)
2.4 Global Atovaquone and Proguanil Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Atovaquone and Proguanil, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atovaquone and Proguanil, Product Type & Application
2.7 Atovaquone and Proguanil Market Competitive Situation and Trends
2.7.1 Atovaquone and Proguanil Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Atovaquone and Proguanil Players Market Share by Revenue
2.7.3 Global Atovaquone and Proguanil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Atovaquone and Proguanil Retrospective Market Scenario by Region
3.1 Global Atovaquone and Proguanil Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Atovaquone and Proguanil Global Atovaquone and Proguanil Sales by Region: 2019-2030
3.2.1 Global Atovaquone and Proguanil Sales by Region: 2019-2024
3.2.2 Global Atovaquone and Proguanil Sales by Region: 2025-2030
3.3 Global Atovaquone and Proguanil Global Atovaquone and Proguanil Revenue by Region: 2019-2030
3.3.1 Global Atovaquone and Proguanil Revenue by Region: 2019-2024
3.3.2 Global Atovaquone and Proguanil Revenue by Region: 2025-2030
3.4 North America Atovaquone and Proguanil Market Facts & Figures by Country
3.4.1 North America Atovaquone and Proguanil Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Atovaquone and Proguanil Sales by Country (2019-2030)
3.4.3 North America Atovaquone and Proguanil Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Atovaquone and Proguanil Market Facts & Figures by Country
3.5.1 Europe Atovaquone and Proguanil Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Atovaquone and Proguanil Sales by Country (2019-2030)
3.5.3 Europe Atovaquone and Proguanil Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atovaquone and Proguanil Market Facts & Figures by Country
3.6.1 Asia Pacific Atovaquone and Proguanil Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Atovaquone and Proguanil Sales by Country (2019-2030)
3.6.3 Asia Pacific Atovaquone and Proguanil Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Atovaquone and Proguanil Market Facts & Figures by Country
3.7.1 Latin America Atovaquone and Proguanil Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Atovaquone and Proguanil Sales by Country (2019-2030)
3.7.3 Latin America Atovaquone and Proguanil Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Atovaquone and Proguanil Market Facts & Figures by Country
3.8.1 Middle East and Africa Atovaquone and Proguanil Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Atovaquone and Proguanil Sales by Country (2019-2030)
3.8.3 Middle East and Africa Atovaquone and Proguanil Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Atovaquone and Proguanil Sales by Type (2019-2030)
4.1.1 Global Atovaquone and Proguanil Sales by Type (2019-2024)
4.1.2 Global Atovaquone and Proguanil Sales by Type (2025-2030)
4.1.3 Global Atovaquone and Proguanil Sales Market Share by Type (2019-2030)
4.2 Global Atovaquone and Proguanil Revenue by Type (2019-2030)
4.2.1 Global Atovaquone and Proguanil Revenue by Type (2019-2024)
4.2.2 Global Atovaquone and Proguanil Revenue by Type (2025-2030)
4.2.3 Global Atovaquone and Proguanil Revenue Market Share by Type (2019-2030)
4.3 Global Atovaquone and Proguanil Price by Type (2019-2030)
5 Segment by Application
5.1 Global Atovaquone and Proguanil Sales by Application (2019-2030)
5.1.1 Global Atovaquone and Proguanil Sales by Application (2019-2024)
5.1.2 Global Atovaquone and Proguanil Sales by Application (2025-2030)
5.1.3 Global Atovaquone and Proguanil Sales Market Share by Application (2019-2030)
5.2 Global Atovaquone and Proguanil Revenue by Application (2019-2030)
5.2.1 Global Atovaquone and Proguanil Revenue by Application (2019-2024)
5.2.2 Global Atovaquone and Proguanil Revenue by Application (2025-2030)
5.2.3 Global Atovaquone and Proguanil Revenue Market Share by Application (2019-2030)
5.3 Global Atovaquone and Proguanil Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Atovaquone and Proguanil Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Atovaquone and Proguanil Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Glenmark
6.2.1 Glenmark Corporation Information
6.2.2 Glenmark Description and Business Overview
6.2.3 Glenmark Atovaquone and Proguanil Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Glenmark Atovaquone and Proguanil Product Portfolio
6.2.5 Glenmark Recent Developments/Updates
6.3 Mylan Pharmaceuticals
6.3.1 Mylan Pharmaceuticals Corporation Information
6.3.2 Mylan Pharmaceuticals Description and Business Overview
6.3.3 Mylan Pharmaceuticals Atovaquone and Proguanil Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Pharmaceuticals Atovaquone and Proguanil Product Portfolio
6.3.5 Mylan Pharmaceuticals Recent Developments/Updates
6.4 Hetero
6.4.1 Hetero Corporation Information
6.4.2 Hetero Description and Business Overview
6.4.3 Hetero Atovaquone and Proguanil Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hetero Atovaquone and Proguanil Product Portfolio
6.4.5 Hetero Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atovaquone and Proguanil Industry Chain Analysis
7.2 Atovaquone and Proguanil Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atovaquone and Proguanil Production Mode & Process
7.4 Atovaquone and Proguanil Sales and Marketing
7.4.1 Atovaquone and Proguanil Sales Channels
7.4.2 Atovaquone and Proguanil Distributors
7.5 Atovaquone and Proguanil Customers
8 Atovaquone and Proguanil Market Dynamics
8.1 Atovaquone and Proguanil Industry Trends
8.2 Atovaquone and Proguanil Market Drivers
8.3 Atovaquone and Proguanil Market Challenges
8.4 Atovaquone and Proguanil Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Atovaquone and Proguanil Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Atovaquone and Proguanil Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Atovaquone and Proguanil Market Competitive Situation by Manufacturers in 2023
Table 4. Global Atovaquone and Proguanil Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Atovaquone and Proguanil Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Atovaquone and Proguanil Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Atovaquone and Proguanil Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Atovaquone and Proguanil Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Atovaquone and Proguanil, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Atovaquone and Proguanil, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Atovaquone and Proguanil, Product Type & Application
Table 12. Global Key Manufacturers of Atovaquone and Proguanil, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Atovaquone and Proguanil by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atovaquone and Proguanil as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Atovaquone and Proguanil Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Atovaquone and Proguanil Sales by Region (2019-2024) & (K Units)
Table 18. Global Atovaquone and Proguanil Sales Market Share by Region (2019-2024)
Table 19. Global Atovaquone and Proguanil Sales by Region (2025-2030) & (K Units)
Table 20. Global Atovaquone and Proguanil Sales Market Share by Region (2025-2030)
Table 21. Global Atovaquone and Proguanil Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Atovaquone and Proguanil Revenue Market Share by Region (2019-2024)
Table 23. Global Atovaquone and Proguanil Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Atovaquone and Proguanil Revenue Market Share by Region (2025-2030)
Table 25. North America Atovaquone and Proguanil Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Atovaquone and Proguanil Sales by Country (2019-2024) & (K Units)
Table 27. North America Atovaquone and Proguanil Sales by Country (2025-2030) & (K Units)
Table 28. North America Atovaquone and Proguanil Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Atovaquone and Proguanil Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Atovaquone and Proguanil Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Atovaquone and Proguanil Sales by Country (2019-2024) & (K Units)
Table 32. Europe Atovaquone and Proguanil Sales by Country (2025-2030) & (K Units)
Table 33. Europe Atovaquone and Proguanil Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Atovaquone and Proguanil Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Atovaquone and Proguanil Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Atovaquone and Proguanil Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Atovaquone and Proguanil Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Atovaquone and Proguanil Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Atovaquone and Proguanil Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Atovaquone and Proguanil Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Atovaquone and Proguanil Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Atovaquone and Proguanil Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Atovaquone and Proguanil Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Atovaquone and Proguanil Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Atovaquone and Proguanil Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Atovaquone and Proguanil Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Atovaquone and Proguanil Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Atovaquone and Proguanil Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Atovaquone and Proguanil Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Atovaquone and Proguanil Sales (K Units) by Type (2019-2024)
Table 51. Global Atovaquone and Proguanil Sales (K Units) by Type (2025-2030)
Table 52. Global Atovaquone and Proguanil Sales Market Share by Type (2019-2024)
Table 53. Global Atovaquone and Proguanil Sales Market Share by Type (2025-2030)
Table 54. Global Atovaquone and Proguanil Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Atovaquone and Proguanil Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Atovaquone and Proguanil Revenue Market Share by Type (2019-2024)
Table 57. Global Atovaquone and Proguanil Revenue Market Share by Type (2025-2030)
Table 58. Global Atovaquone and Proguanil Price (USD/Unit) by Type (2019-2024)
Table 59. Global Atovaquone and Proguanil Price (USD/Unit) by Type (2025-2030)
Table 60. Global Atovaquone and Proguanil Sales (K Units) by Application (2019-2024)
Table 61. Global Atovaquone and Proguanil Sales (K Units) by Application (2025-2030)
Table 62. Global Atovaquone and Proguanil Sales Market Share by Application (2019-2024)
Table 63. Global Atovaquone and Proguanil Sales Market Share by Application (2025-2030)
Table 64. Global Atovaquone and Proguanil Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Atovaquone and Proguanil Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Atovaquone and Proguanil Revenue Market Share by Application (2019-2024)
Table 67. Global Atovaquone and Proguanil Revenue Market Share by Application (2025-2030)
Table 68. Global Atovaquone and Proguanil Price (USD/Unit) by Application (2019-2024)
Table 69. Global Atovaquone and Proguanil Price (USD/Unit) by Application (2025-2030)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Atovaquone and Proguanil Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. GSK Atovaquone and Proguanil Product
Table 74. GSK Recent Developments/Updates
Table 75. Glenmark Corporation Information
Table 76. Glenmark Description and Business Overview
Table 77. Glenmark Atovaquone and Proguanil Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Glenmark Atovaquone and Proguanil Product
Table 79. Glenmark Recent Developments/Updates
Table 80. Mylan Pharmaceuticals Corporation Information
Table 81. Mylan Pharmaceuticals Description and Business Overview
Table 82. Mylan Pharmaceuticals Atovaquone and Proguanil Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Mylan Pharmaceuticals Atovaquone and Proguanil Product
Table 84. Mylan Pharmaceuticals Recent Developments/Updates
Table 85. Hetero Corporation Information
Table 86. Hetero Description and Business Overview
Table 87. Hetero Atovaquone and Proguanil Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Hetero Atovaquone and Proguanil Product
Table 89. Hetero Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Atovaquone and Proguanil Distributors List
Table 93. Atovaquone and Proguanil Customers List
Table 94. Atovaquone and Proguanil Market Trends
Table 95. Atovaquone and Proguanil Market Drivers
Table 96. Atovaquone and Proguanil Market Challenges
Table 97. Atovaquone and Proguanil Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Atovaquone and Proguanil
Figure 2. Global Atovaquone and Proguanil Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Atovaquone and Proguanil Market Share by Type in 2023 & 2030
Figure 4. 250 mg/100 mg Product Picture
Figure 5. 62.5mg/25mg Product Picture
Figure 6. Global Atovaquone and Proguanil Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Atovaquone and Proguanil Market Share by Application in 2023 & 2030
Figure 8. Adult
Figure 9. Paediatric
Figure 10. Global Atovaquone and Proguanil Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Atovaquone and Proguanil Market Size (2019-2030) & (US$ Million)
Figure 12. Global Atovaquone and Proguanil Sales (2019-2030) & (K Units)
Figure 13. Global Atovaquone and Proguanil Average Price (USD/Unit) & (2019-2030)
Figure 14. Atovaquone and Proguanil Report Years Considered
Figure 15. Atovaquone and Proguanil Sales Share by Manufacturers in 2023
Figure 16. Global Atovaquone and Proguanil Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Atovaquone and Proguanil Players: Market Share by Revenue in 2023
Figure 18. Atovaquone and Proguanil Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Atovaquone and Proguanil Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Atovaquone and Proguanil Sales Market Share by Country (2019-2030)
Figure 21. North America Atovaquone and Proguanil Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Atovaquone and Proguanil Sales Market Share by Country (2019-2030)
Figure 25. Europe Atovaquone and Proguanil Revenue Market Share by Country (2019-2030)
Figure 26. Germany Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Atovaquone and Proguanil Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Atovaquone and Proguanil Revenue Market Share by Region (2019-2030)
Figure 33. China Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Atovaquone and Proguanil Sales Market Share by Country (2019-2030)
Figure 44. Latin America Atovaquone and Proguanil Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Atovaquone and Proguanil Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Atovaquone and Proguanil Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Atovaquone and Proguanil by Type (2019-2030)
Figure 54. Global Revenue Market Share of Atovaquone and Proguanil by Type (2019-2030)
Figure 55. Global Atovaquone and Proguanil Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Atovaquone and Proguanil by Application (2019-2030)
Figure 57. Global Revenue Market Share of Atovaquone and Proguanil by Application (2019-2030)
Figure 58. Global Atovaquone and Proguanil Price (USD/Unit) by Application (2019-2030)
Figure 59. Atovaquone and Proguanil Value Chain
Figure 60. Atovaquone and Proguanil Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Atovaquone and Proguanil Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Atovaquone and Proguanil Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Atovaquone and Proguanil Market Competitive Situation by Manufacturers in 2023
Table 4. Global Atovaquone and Proguanil Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Atovaquone and Proguanil Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Atovaquone and Proguanil Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Atovaquone and Proguanil Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Atovaquone and Proguanil Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Atovaquone and Proguanil, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Atovaquone and Proguanil, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Atovaquone and Proguanil, Product Type & Application
Table 12. Global Key Manufacturers of Atovaquone and Proguanil, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Atovaquone and Proguanil by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atovaquone and Proguanil as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Atovaquone and Proguanil Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Atovaquone and Proguanil Sales by Region (2019-2024) & (K Units)
Table 18. Global Atovaquone and Proguanil Sales Market Share by Region (2019-2024)
Table 19. Global Atovaquone and Proguanil Sales by Region (2025-2030) & (K Units)
Table 20. Global Atovaquone and Proguanil Sales Market Share by Region (2025-2030)
Table 21. Global Atovaquone and Proguanil Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Atovaquone and Proguanil Revenue Market Share by Region (2019-2024)
Table 23. Global Atovaquone and Proguanil Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Atovaquone and Proguanil Revenue Market Share by Region (2025-2030)
Table 25. North America Atovaquone and Proguanil Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Atovaquone and Proguanil Sales by Country (2019-2024) & (K Units)
Table 27. North America Atovaquone and Proguanil Sales by Country (2025-2030) & (K Units)
Table 28. North America Atovaquone and Proguanil Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Atovaquone and Proguanil Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Atovaquone and Proguanil Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Atovaquone and Proguanil Sales by Country (2019-2024) & (K Units)
Table 32. Europe Atovaquone and Proguanil Sales by Country (2025-2030) & (K Units)
Table 33. Europe Atovaquone and Proguanil Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Atovaquone and Proguanil Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Atovaquone and Proguanil Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Atovaquone and Proguanil Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Atovaquone and Proguanil Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Atovaquone and Proguanil Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Atovaquone and Proguanil Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Atovaquone and Proguanil Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Atovaquone and Proguanil Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Atovaquone and Proguanil Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Atovaquone and Proguanil Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Atovaquone and Proguanil Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Atovaquone and Proguanil Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Atovaquone and Proguanil Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Atovaquone and Proguanil Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Atovaquone and Proguanil Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Atovaquone and Proguanil Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Atovaquone and Proguanil Sales (K Units) by Type (2019-2024)
Table 51. Global Atovaquone and Proguanil Sales (K Units) by Type (2025-2030)
Table 52. Global Atovaquone and Proguanil Sales Market Share by Type (2019-2024)
Table 53. Global Atovaquone and Proguanil Sales Market Share by Type (2025-2030)
Table 54. Global Atovaquone and Proguanil Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Atovaquone and Proguanil Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Atovaquone and Proguanil Revenue Market Share by Type (2019-2024)
Table 57. Global Atovaquone and Proguanil Revenue Market Share by Type (2025-2030)
Table 58. Global Atovaquone and Proguanil Price (USD/Unit) by Type (2019-2024)
Table 59. Global Atovaquone and Proguanil Price (USD/Unit) by Type (2025-2030)
Table 60. Global Atovaquone and Proguanil Sales (K Units) by Application (2019-2024)
Table 61. Global Atovaquone and Proguanil Sales (K Units) by Application (2025-2030)
Table 62. Global Atovaquone and Proguanil Sales Market Share by Application (2019-2024)
Table 63. Global Atovaquone and Proguanil Sales Market Share by Application (2025-2030)
Table 64. Global Atovaquone and Proguanil Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Atovaquone and Proguanil Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Atovaquone and Proguanil Revenue Market Share by Application (2019-2024)
Table 67. Global Atovaquone and Proguanil Revenue Market Share by Application (2025-2030)
Table 68. Global Atovaquone and Proguanil Price (USD/Unit) by Application (2019-2024)
Table 69. Global Atovaquone and Proguanil Price (USD/Unit) by Application (2025-2030)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Atovaquone and Proguanil Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. GSK Atovaquone and Proguanil Product
Table 74. GSK Recent Developments/Updates
Table 75. Glenmark Corporation Information
Table 76. Glenmark Description and Business Overview
Table 77. Glenmark Atovaquone and Proguanil Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Glenmark Atovaquone and Proguanil Product
Table 79. Glenmark Recent Developments/Updates
Table 80. Mylan Pharmaceuticals Corporation Information
Table 81. Mylan Pharmaceuticals Description and Business Overview
Table 82. Mylan Pharmaceuticals Atovaquone and Proguanil Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Mylan Pharmaceuticals Atovaquone and Proguanil Product
Table 84. Mylan Pharmaceuticals Recent Developments/Updates
Table 85. Hetero Corporation Information
Table 86. Hetero Description and Business Overview
Table 87. Hetero Atovaquone and Proguanil Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Hetero Atovaquone and Proguanil Product
Table 89. Hetero Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Atovaquone and Proguanil Distributors List
Table 93. Atovaquone and Proguanil Customers List
Table 94. Atovaquone and Proguanil Market Trends
Table 95. Atovaquone and Proguanil Market Drivers
Table 96. Atovaquone and Proguanil Market Challenges
Table 97. Atovaquone and Proguanil Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Atovaquone and Proguanil
Figure 2. Global Atovaquone and Proguanil Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Atovaquone and Proguanil Market Share by Type in 2023 & 2030
Figure 4. 250 mg/100 mg Product Picture
Figure 5. 62.5mg/25mg Product Picture
Figure 6. Global Atovaquone and Proguanil Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Atovaquone and Proguanil Market Share by Application in 2023 & 2030
Figure 8. Adult
Figure 9. Paediatric
Figure 10. Global Atovaquone and Proguanil Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Atovaquone and Proguanil Market Size (2019-2030) & (US$ Million)
Figure 12. Global Atovaquone and Proguanil Sales (2019-2030) & (K Units)
Figure 13. Global Atovaquone and Proguanil Average Price (USD/Unit) & (2019-2030)
Figure 14. Atovaquone and Proguanil Report Years Considered
Figure 15. Atovaquone and Proguanil Sales Share by Manufacturers in 2023
Figure 16. Global Atovaquone and Proguanil Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Atovaquone and Proguanil Players: Market Share by Revenue in 2023
Figure 18. Atovaquone and Proguanil Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Atovaquone and Proguanil Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Atovaquone and Proguanil Sales Market Share by Country (2019-2030)
Figure 21. North America Atovaquone and Proguanil Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Atovaquone and Proguanil Sales Market Share by Country (2019-2030)
Figure 25. Europe Atovaquone and Proguanil Revenue Market Share by Country (2019-2030)
Figure 26. Germany Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Atovaquone and Proguanil Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Atovaquone and Proguanil Revenue Market Share by Region (2019-2030)
Figure 33. China Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Atovaquone and Proguanil Sales Market Share by Country (2019-2030)
Figure 44. Latin America Atovaquone and Proguanil Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Atovaquone and Proguanil Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Atovaquone and Proguanil Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Atovaquone and Proguanil Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Atovaquone and Proguanil by Type (2019-2030)
Figure 54. Global Revenue Market Share of Atovaquone and Proguanil by Type (2019-2030)
Figure 55. Global Atovaquone and Proguanil Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Atovaquone and Proguanil by Application (2019-2030)
Figure 57. Global Revenue Market Share of Atovaquone and Proguanil by Application (2019-2030)
Figure 58. Global Atovaquone and Proguanil Price (USD/Unit) by Application (2019-2030)
Figure 59. Atovaquone and Proguanil Value Chain
Figure 60. Atovaquone and Proguanil Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232